Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|August 27, 2013
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cellsJun Koshio, Hiroshi Kagamu, Koichiro Nozaki, et al.
Antioxidants & Redox Signaling|April 13, 2023
Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination DNA RepairYasunori Otowa, Shun Kishimoto, Yu Saida, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Improved Tumor Blood Flow Enhances the Abscopal Effect: Preclinical Assessment in Mice Treated with Combined Radiation and PD-1 Blockade TherapyKota Yamashita, Jeffrey R Brender, Yu Saida, et al.
Neoplasia (New York, N.Y.)|May 6, 2022
PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging studyTomohiro Seki, Yu Saida, Shun Kishimoto, et al.
Academic Radiology|September 3, 2024
<sup>18</sup>F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint InhibitorsMotohiko Yamazaki, Satoshi Watanabe, Masaki Tominaga, et al.
Translational Lung Cancer Research|March 4, 2022
Prognostic significance of procalcitonin in small cell lung cancerKosuke Ichikawa, Satoshi Watanabe, Satoru Miura, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trialTetsuhiko Asao, Yu Saida, Satoshi Watanabe, et al.
Thoracic Cancer|June 17, 2026
Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy ResistanceKensuke Yanai, Tomohiro Tanaka, Konomi Kimura, et al.
Blood|July 19, 2012
Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopeniaJunko Baba, Satoshi Watanabe, Yu Saida, et al.
Oncology Letters|February 26, 2026
Successful treatment with tepotinib followed by pembrolizumab in pulmonary pleomorphic carcinoma harbouring a <i>MET</i> exon 14 skipping mutation: A case reportSusumu Tanaka, Yu Saida, Yumi Ando, et al.
Pageof 3